{
    "clinical_study": {
        "@rank": "116202", 
        "brief_summary": {
            "textblock": "To evaluate ampligen at two dosage levels given twice weekly in combination with zidovudine\n      (AZT) versus AZT alone in individuals with HIV-related immune dysfunction defined as T4\n      count between 100 and 300 cells/mm3."
        }, 
        "brief_title": "A Multicenter, Double-Blind, Controlled Study to Evaluate Ampligen", 
        "condition": "HIV Infections", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patients must have:\n\n          -  HIV-1 seropositivity.\n\n          -  Absolute number of T4 cells 100-300 cells/mm3.\n\n          -  Given informed consent.\n\n          -  Zidovudine (AZT) therapy for 6 months prior to study entry.\n\n          -  At least one of the listed HIV-related clinical symptoms or opportunistic infections:\n\n          -  weight loss > 10 percent, unexplained diarrhea, unexplained intermittent fever, oral\n             candidiasis > 1 month, decreased Karnofsky, oral hairy leukoplakia, chronic fatigue.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following conditions or symptoms are excluded:\n\n          -  Evidence of AIDS.\n\n          -  Intercurrent acute medical disorder.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Chemotherapy for Kaposi's sarcoma (KS).\n\n          -  Aspirin.\n\n          -  Non-steroidal anti-inflammatory drugs.\n\n        Patients with the following are excluded:\n\n          -  Inability to return for treatment and evaluation for 12 months.\n\n          -  Intercurrent acute medical disorder.\n\n          -  Evidence of AIDS.\n\n          -  Receiving chemotherapy for Kaposi's sarcoma (KS).\n\n          -  Unwilling or unable to give informed consent.\n\n        Required:\n\n          -  Zidovudine (AZT).\n\n        Required at least 6 months prior to study entry:\n\n          -  Zidovudine (AZT).\n\n        Active drug abuse."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002269", 
            "org_study_id": "073A", 
            "secondary_id": "AMP-700"
        }, 
        "intervention": [
            {
                "intervention_name": "Ampligen", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Zidovudine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Zidovudine", 
                "Ampligen"
            ]
        }, 
        "keyword": [
            "Acquired Immunodeficiency Syndrome", 
            "ampligen", 
            "AIDS-Related Complex", 
            "Zidovudine"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33125"
                    }, 
                    "name": "Miami Veterans Administration Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97201"
                    }, 
                    "name": "Oregon Health Sciences Univ"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19102"
                    }, 
                    "name": "MCP Hahnemann Univ Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75219"
                    }, 
                    "name": "Nelson Tebedo Community Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77054"
                    }, 
                    "name": "Dr Patricia Salvato"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Multicenter, Double-Blind, Controlled Study to Evaluate Ampligen", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002269"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "HEM Research", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 1991"
    }, 
    "geocoordinates": {
        "Dr Patricia Salvato": "29.76 -95.369", 
        "MCP Hahnemann Univ Hosp": "39.952 -75.164", 
        "Miami Veterans Administration Med Ctr": "25.789 -80.226", 
        "Nelson Tebedo Community Clinic": "32.803 -96.77", 
        "Oregon Health Sciences Univ": "45.523 -122.676"
    }
}